Duke Health contracts with most major health insurance carriers and transplant networks, including the ones listed below. Before scheduling your appointment, we strongly recommend you contact your insurance company to verify that the Duke Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any co-payments, co–insurances, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with Duke, your out of pocket liability may be higher. We will contact you regarding your coverage and patient liability. If you are uninsured, learn more about our financial assistance policy.
William Schuyler Jones, MD
I usually take care of two types of patients. One is patients with coronary artery disease who have blockages in the heart arteries. The other is peripheral artery disease with blockages in the leg arteries. I treat patients both in the clinic and in the hospital. In the hospital, I provide treatment opening these blockages with balloons and stents. Duke is unique because of its ability to provide innovative treatments to patients. A lot of places around the state and country can provide standard of care, and I think Duke does a really good job of offering that. But the thing that really sets Duke apart is the ability to go one step further and provide new treatments that may provide benefits that others can’t offer. I met a patient early in my training who really had no options for treatment. She had a blockage in a leg artery that we could not open with a balloon and stent. We injected her with cells under a research protocol, and she really experienced a tremendous benefit. We thought it would be short-lasting but we saw her back a couple of months ago and she’s still doing well. That really solidified my interest in doing research on these novel, innovative treatments to our patients.
Clinical Focus and Research
My research interests are aligned with the patients that I see in the clinic and in the hospital. My primary goal is to improve the care of patients with coronary artery disease (heart artery blockages) and peripheral artery disease (blockages in arteries of the legs, kidneys and brain). Much of my research occurs at the Duke Clinical Research Institute where we conduct multicenter clinical trials and perform analyses of existing datasets. I also lead our cath lab research group where we offer novel diagnostic tests and treatment options to our patients at Duke.
View William Jones's publications on PubMed
- First Health
- Gateway Health Alliance
- Halifax Physician-Hospital Organization
- MultiPlan / Private Healthcare Systems
- OneNet PPO
Industry Relationships and Collaborations
This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.
- Bristol-Myers Squibb
- Eclipse Health Outcomes
- Janssen Pharmaceuticals (Johnson & Johnson)
- Medtronic (Covidien)